SR0987

CAS No. 303126-97-8

SR0987( SR-0987 | SR0987 | SR 0987 )

Catalog No. M19376 CAS No. 303126-97-8

SR0987 is a RORγt agonist,

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 58 In Stock
10MG 102 In Stock
25MG 205 In Stock
50MG 357 In Stock
100MG 530 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SR0987
  • Note
    Research use only, not for human use.
  • Brief Description
    SR0987 is a RORγt agonist,
  • Description
    SR-0987 is a T cell-specific RORγ (RORγt) agonist. SR-0987 induces IL-17 expression and decreases PD-1 expression in T cells in vitro.
  • In Vitro
    SR0987 clearly shows a concentration dependent induction of reporter gene expression with an EC50 of ~800nM. SR0987 treatment results in a statistically significant reduction of the surface expression of PD-1 whereas desmostrol treatment shows no effect. Treatment with SR0987 and or desmosterol results in a trend towards increased IL17 production.
  • In Vivo
    ——
  • Synonyms
    SR-0987 | SR0987 | SR 0987
  • Pathway
    Nuclear Receptor/Transcription Factor
  • Target
    ROR
  • Recptor
    RORγt
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    303126-97-8
  • Formula Weight
    397.7
  • Molecular Formula
    C16H10ClF6NO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 150 mg/mL 377.17 mM H2O : < 0.1 mg/mL
  • SMILES
    O=C(Nc1ccc(cc1)C(O)(C(F)(F)F)C(F)(F)F)c2ccccc2Cl
  • Chemical Name
    2-Chloro-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chang MR, et al. Synthetic RORγt Agonists Enhance Protective Immunity. ACS Chem Biol. 2016 Apr 15;11(4):1012-8.
molnova catalog
related products
  • VTP-43742

    VTP-43742 (Vimirogant, VTP43742) is a?highly potent, selective, oral RORγt inverse agonist for the treatment of autoimmune disorders.

  • ML 209

    ML-209 is an antagonist of retinoic acid receptor-related orphan receptor γt (RORγt; IC50= 1.1 μM in a reporter assay).1It inhibits RORγt-induced transcription in HEK293T cells expressing the human receptor (IC50= 300 nM).

  • Bevurogant

    Bevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases.